ZKGZ 008
Alternative Names: ZKGZ-008Latest Information Update: 05 Feb 2021
At a glance
- Originator Zhaoke Pharmaceutical (Guangzhou)
- Class Cardiovascular therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cardiovascular disorders
Most Recent Events
- 10 Dec 2020 Preclinical trials in Cardiovascular disorders in China (unspecified route) before December 2020 (Lee's Pharmaceutical pipeline, December 2020)